The albuminuria-lowering response to dapagliflozin is variable and reproducible among individual patients
Author:
Affiliation:
1. Department of Clinical Pharmacy and Pharmacology; University of Groningen, University Medical Center Groningen; Groningen the Netherlands
2. Department of Nephrology; Ziekenhuisgroep Twente; Almelo and Hengelo the Netherlands
Funder
Astra Zeneca
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12936/fullpdf
Reference22 articles.
1. Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes;Defronzo;Diabetes Care,2013
2. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial;Bailey;Lancet,2010
3. Dapagliflozin: a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes;Lambers Heerspink;Diabetes Obes Metab,2013
4. Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers;Heerspink;Diabetes Obes Metab,2016
5. Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease;Yale;Diabetes Obes Metab,2013
Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects of SGLT2 inhibitors on parameters of renal venous congestion in intrarenal Doppler ultrasonography;Clinical Kidney Journal;2024-08-14
2. Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease;Kidney International Reports;2024-06
3. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes;Cochrane Database of Systematic Reviews;2024-05-21
4. Biomarkers and Precision Medicine in Diabetes;Textbook of Diabetes;2024-01-12
5. Assessment of effects of combination of SGLT2 inhibitors and renin–angiotensin–aldosterone system blockers on the renal functions of patients of diabetic kidney disease (SGRASS-DKD study);Journal of Diabetology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3